
RNA Analysis/Transcriptomics Market by Product (Instruments, Reagents or Consumables, Services), Technology (Microarrays, Polymerase Chain Reaction, RNA Interference), Application, End-User - Global Forecast 2024-2030
Description
RNA Analysis/Transcriptomics Market by Product (Instruments, Reagents or Consumables, Services), Technology (Microarrays, Polymerase Chain Reaction, RNA Interference), Application, End-User - Global Forecast 2024-2030
The RNA Analysis/Transcriptomics Market size was estimated at USD 5.37 billion in 2023 and expected to reach USD 5.92 billion in 2024, at a CAGR 10.49% to reach USD 10.79 billion by 2030.
Global RNA Analysis/Transcriptomics Market
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the RNA Analysis/Transcriptomics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the RNA Analysis/Transcriptomics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the RNA Analysis/Transcriptomics Market, highlighting leading vendors and their innovative profiles. These include Acobiom, Affymetrix, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., CD Genomics, Cenix BioScience GmbH, Danaher Corporation, Eurofins Scientific, F. Hoffmann-La Roche Ltd., Fluidigm Corporation, GenXPro GmbH, Illumina, Inc., Lexogen GmbH, Merck KGaA, Pacific Bioscience of California, Inc., Promega Corporation, QIAGEN N.V., Sequentia Biotech SL, and Thermo Fisher Scientific, Inc..
Market Segmentation & Coverage
This research report categorizes the RNA Analysis/Transcriptomics Market to forecast the revenues and analyze trends in each of the following sub-markets:
Product
Instruments
Reagents or Consumables
Services
Software
Technology
Microarrays
Polymerase Chain Reaction
RNA Interference
Sequencing
Application
Clinical Diagnostics
Comparative Transcriptomics
Drug Discovery
Toxicogenomics
End-User
Academic & Research Institutes
Contract Research Organizations
Hospitals
Pharmaceutical & Biotechnology Companies
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the RNA Analysis/Transcriptomics Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the RNA Analysis/Transcriptomics Market?
3. What are the technology trends and regulatory frameworks in the RNA Analysis/Transcriptomics Market?
4. What is the market share of the leading vendors in the RNA Analysis/Transcriptomics Market?
5. Which modes and strategic moves are suitable for entering the RNA Analysis/Transcriptomics Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
199 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. RNA Analysis/Transcriptomics Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. High Inclination Toward RNA Analysis Over DNA Leading to Growth in RNA Transcriptomics Applications
- 5.1.1.2. Rising Demand for Personalized Medicine and Targeted Therapeutics
- 5.1.1.3. Growing Pharmaceutical and Biotechnology R&D Expenditure and Government Funding for Omics
- 5.1.2. Restraints
- 5.1.2.1. Expensive R&D and Issues Related to Data Management
- 5.1.3. Opportunities
- 5.1.3.1. Increasing Focus on Biomarker
- 5.1.3.2. State-of-the-art RNAi Therapies In Development
- 5.1.4. Challenges
- 5.1.4.1. Lack of Effective Bioinformatics Tools
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. RNA Analysis/Transcriptomics Market, by Product
- 6.1. Introduction
- 6.2. Instruments
- 6.3. Reagents or Consumables
- 6.4. Services
- 6.5. Software
- 7. RNA Analysis/Transcriptomics Market, by Technology
- 7.1. Introduction
- 7.2. Microarrays
- 7.3. Polymerase Chain Reaction
- 7.4. RNA Interference
- 7.5. Sequencing
- 8. RNA Analysis/Transcriptomics Market, by Application
- 8.1. Introduction
- 8.2. Clinical Diagnostics
- 8.3. Comparative Transcriptomics
- 8.4. Drug Discovery
- 8.5. Toxicogenomics
- 9. RNA Analysis/Transcriptomics Market, by End-User
- 9.1. Introduction
- 9.2. Academic & Research Institutes
- 9.3. Contract Research Organizations
- 9.4. Hospitals
- 9.5. Pharmaceutical & Biotechnology Companies
- 10. Americas RNA Analysis/Transcriptomics Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific RNA Analysis/Transcriptomics Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa RNA Analysis/Transcriptomics Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. Acobiom
- 14.1.2. Affymetrix, Inc.
- 14.1.3. Agilent Technologies, Inc.
- 14.1.4. Bio-Rad Laboratories, Inc.
- 14.1.5. CD Genomics
- 14.1.6. Cenix BioScience GmbH
- 14.1.7. Danaher Corporation
- 14.1.8. Eurofins Scientific
- 14.1.9. F. Hoffmann-La Roche Ltd.
- 14.1.10. Fluidigm Corporation
- 14.1.11. GenXPro GmbH
- 14.1.12. Illumina, Inc.
- 14.1.13. Lexogen GmbH
- 14.1.14. Merck KGaA
- 14.1.15. Pacific Bioscience of California, Inc.
- 14.1.16. Promega Corporation
- 14.1.17. QIAGEN N.V.
- 14.1.18. Sequentia Biotech SL
- 14.1.19. Thermo Fisher Scientific, Inc.
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
- FIGURE 1. RNA ANALYSIS/TRANSCRIPTOMICS MARKET RESEARCH PROCESS
- FIGURE 2. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2023 VS 2030
- FIGURE 3. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. RNA ANALYSIS/TRANSCRIPTOMICS MARKET DYNAMICS
- FIGURE 7. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 8. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
- FIGURE 10. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 12. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 14. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. AMERICAS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. AMERICAS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 18. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. RNA ANALYSIS/TRANSCRIPTOMICS MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 24. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.